About AIER News Social Responsibility
Professor Peng Xiaoyan, a renowned specialist in fundus and difficult eye diseases, joins Aier Hospital Group Caring for veterans' eye health, "Warmth for veterans - Guarding the light" public welfare action launched in Beijing Accelerating the accumulation of data assets and popularizing high-level ophthalmic medical services with artificial intelligence - AIER continues to work with the Chinese Academy of Sciences on digital ophthalmology development strategies The first new generation of astigmatism-correcting cataract surgery in China was successfully completed at AIER Prof. Zheng Wang has been invited to become a Fellow of the World College of Refractive Surgery and Vision Science (WCRS)! Ministry of Science and Technology's key research and development project lands in AIER for the first time, focusing on myopia prevention and control Talent planning - AIER launched the "Beidou talent plan", to build a global ophthalmic talent ecosystem The alliance between giants - AIER and China Eye Valley shows a sound momentum of all-round and in-depth eye health development AIER will donate 20 billion yuan in the next ten years to build a sustainable eye healthcare ecosystem Living up to our responsibility！ AIER received the Top 500 Chinese Brand Value Award with the "Huapu Award" for three consecutive years The research results of Prof. Jiansu Chen and Shibo Tang’s team from AIER were published in the International journal (impact factor: 10.633) Professor Fengyuan Sun, an oculoplastic & orbit disease expert in China, joined AIER to build the "Last Stop" for the diagnosis and treatment of intractable diseases 2021 AIER EYE HOSPITAL GROUP CO., LTD. Social Responsibility Report Prof. Weizhong Lan from AIER was invited to WHO-ITU Be He@lthy, Be Mobile toolkit for the myopia launch meeting AIER Eye Hospital Group donates 2 million yuan to Suzhou fight against the pandemic — Caring donation before Suzhou AIER Eye Hospital officially open AIER Eye Hospital Group received “The Red Cross Award of China” Prof. ZhiKuan Yang of AIER was elected president of the second council of Hunan Optometric Association Prof. Shibo Tang from AIER received the "China Industry-University-Research Collaboration Innovation and Promotion Award" AIER receives “Best Information Disclosure Award”by the Excellence IR School-enterprise cooperation making new progress by providing opportunities and platforms for talents to stand out - AIER and Henan University agreed to establish a strategic partnership AIER Clinic of Myopia Prevention for Teenagers: " 5P Model for Myopic Prevention" 6 billion RMB! A new university in Changsha - AIER International Medical College project signed Strategic Alliance Formed Between AIER and Sichuan University Protecting children and teenager’s eye health, "Red Cross Eye Protection Program " officially launched in Beijing Speech from Mr. Bang Chen on the China Charity Culture Forum: National consciousness and global mindset from AIER AIER Eye Hospital Group officially has a seat on the board of the World Association of Eye Hospital AIER won the "China Charity Awards" for two consecutive years Professor Jiansu Chen’s team from AIER researched the human corneal stromal cells from SMILE surgery The graduation ceremony of AIER School of Ophthalmology, CSU was held grandly, nearly 200 talents were trained in 6 years. The Rescue: AIER donates 5 million yuan to support disaster relief in Henan province. Malaysian Royal Datuk: Such a good doctor and team should be known to the world! From “poverty-alleviation” to “rural revitalization” AIER Is on the way to making brighter China mission possible Mr. Bang Chen, Chairman of AIER Eye Hospital Group, has been honored as "Excellent Builder of Socialism with Chinese Characteristics" ​Tianjin University AIER Eye Hospital opening ceremony was founded AIER and Singapore Eye Institute jointly tackle the key issues to build a whole chain of myopia research system Research team was led by principal of Jinan University, negotiating a tie-up cooperation with AIER. Optometry talent training accelerated; strategic alliance formed between Tianjin Vocational Institute & AIER Alliance between giants - AIER and the Chinese Academy of Sciences launch the STS "Smart Eye Care" project The number of SCI papers of AIER School of Ophthalmology CSU ranks among the top 20 in China Prospering in the pandemic : 2020's top 100 companies - AIER The awarding ceremony of "National Post-doctoral Research Workstation" of AIER was held in Changsha In the new round of national science & technology innovation platform construction, AIER is listed as the key cultivation object in Hunan Lan Wu, Deputy Secretary of the CPC Hunan Provincial Committee: Support AIER to grow bigger, benefit the eye health industry with more efforts. AIER is named as "The Most Influential 30 Listed Companies in 2020" Strategic Alliance Formed Between Anhui Medical University & AIER to Build a First-class Platform for Ophthalmology in Central China AIER Receives "Huapu Award" and "Anti-Epidemic Tribute Brand Enterprise" at China Brand Festival 2020 AIER Supports CSU with Double First-Class University Project, Rewarding All Medical Staff in Frontline Strategic Alliance Formed Between Jinan University & AIER to Build a First-class Platform for Ophthalmology Annual report of AIER Eye Hospital Group in 2019 Salute to all cornea donors Report of AIER's Fighting against COVID-19 Mourning to Doctor Li Wenliang AIER is Selected into CSI 100 Index International Retina Summit Forum 2019 Grandly opened, AIER Released the Big Data Report on Fundus Disease in Chinease Population Allied AIER & Novartis Establish an Innovative Mode for Chinese Eye Disease Diagnosis & Treatment Five AIER Eye Hospitals Certified by GCP AIER Selected as "Top 20 Competitive Chinese Pharmaceutical Listed Companies of 2019" Together We are Stronger - AIER & Alcon Global Strategic Cooperation Conference Held at Alcon Headquarter AIER Wins Bid for the 19th International Myopia Conference AIER: Exploring Innovation-Integrated Development Model, Sharing Global Vision AIER Acquires ISEC Group, One Big Step in the Belt&Road AIER's Talent Strategies for the Next Decade are Officially Released Led by AIER, the first National Hereditary Eye Diseases Committee is founded Huawei & Talkweb Join AIER to Build an Ophthalmic Medical Industry Ecosystem Enhance Innovation Ability, AIER Create a New Translation Model AIER Opens Up A New Era of Personalizing Myopia Prevent and Control Talent Strategy Helps "100-Year AIER" Dream AIER Eye Hospital Group was awarded the highest government award for charity - China Charity Award IOC - AIER Work Together for Training International High-end Ophthalmology Talents "Shigatse Charity Brightness Action" Helped Nearly 50 Tibetans Regain Their Vision AIER Eye Hospital Group Europe Holding Company Clinica Baviera Successfully Listed in Spain Focus on the New Trend of Global Refractive Surgery Grand opening of 2018 International Refractive Surgery Symposium AIER Eye Hospital Group Releases New Laser Surgery Technology-Smart 3D Prolonged Mobile Phone Use Accelerates the Incidence of Multiple Eye Diseases The Second Phase of "Lancang-Mekong Brightness Action" was Launched in Cambodia China Will Take the Lead to Solve the "Century Problem" of the Pathogenesis of Individual's Myopia AIER Eye Hospital Group is awarded China's Top 10 Investor-Respected Listed Company Aagain! Experts From AIER Have Gotten A Lot of Traction at Retina China 2018 Cooperating with Singapore National Eye Center and Singapore Eye Research Institute "China Bethune" is Famous Among Vietnamese AIER Institute for Corneal Disease Established, Dedicate to Improve China’s Medical Level for Corneal Diseases AIER Was Invited To Attend The Annual Conference Of The International Children's Vision Health Program Precision Anti-Poverty Operation: for 2000 Impoverished Patients in Xiangxi Breaking News: AIER Won the "2017 Excellent Public Welfare Project" Myopia Prevention and Control-Strategy & Perspective - Boao Forum for Vision 2017 2017 International Retina Summit (IRS) Closing AIER Reaches The Target of 200 Hospitals in Mainland China Earlier AIER’s Experts Won Awards at the 35th Congress of ESCRS Chinese Eye Hospital Group Completes Acquisition of Spanish Clinica Baviera "Visual Health Precision Poverty Alleviation Action" For Half a Million Impoverish Patients AIER Eye Hospital Group Acquired Clínica Baviera AIER Joints INTEL to Create Artificial Intelligence Eye Disease Identification Solutions Ieyecloud Private Eye Doctors Providing Signed Patients With Online Eye Health Services Big Data Technology, New Direction for Clinical Prevention and Control of Myopia AIER Eye Hospital Group Acquired AW Healthcare Management
AIER and Singapore Eye Institute jointly tackle the key issues to build a whole chain of myopia research system

2021-06-07 00:00:00


 

image.gif

AIER Optometry Institute and Singapore Eye Institute - a world-renowned eye institution, officially launched the "Adult High Myopia Cohort Study Project." 

 

Currently, the incidence of myopia among adolescents in China ranks first in the world. With the increasing number of people with myopia and high myopia, the resulting number of pathological myopias causing blindness is also increasing, and pathological myopia has become one of the major causes of visual impairment and blindness worldwide. On the afternoon of May 7th, AIER Optometry Institute and Singapore Eye Institute (referred to as SERI), a world-renowned eye institution, officially launched the "Adult High Myopia Cohort Study Project". It is expected that in the next 5-10 years, the two sides will jointly tackle the problem of risk factors and pathogenesis of pathological myopia, so as to provide solutions to the difficulty of preventing high myopia from developing into pathological myopia, ultimately achieve the goal of reducing the blindness rate of high myopia.

 

 

It is reported that the project focuses on the field of myopia technological highland in high myopia and pathological myopia, it is expected to find ways to prevent, screen and treat high levels of myopia worldwide, with more innovative approaches. In addition, three normative guidelines on the prevention, screening, clinical diagnosis and treatment of pathological myopia are established, which is anticipated to fill the gap in the field of pathogenesis of human pathological myopia, to provide technical guidance and codes of practice for the prevention and treatment of pathological myopia for ophthalmologists around the world. 

We learned that this is the first scientific collaborative project between AIER Optometry Institute and SERI.

 

 

Prof.Aung Tin, Director of the SERI, Prof. Ecosse Lamoureux, Director of Department of Population Health and Epidemiology, Prof.Saw Seang Mei, Head of Myopia Research Unit, Dr. Wong Chee Wai, the Principal Investigator of the Clinical Study Project, Prof. Zhikuan Yang, Director of AIER Optometry Institute & Visual Science, Prof. Weizhong Lan, Deputy Director of AIER Optometry Institute & Visual Science, Prof. Zhongping Chen, Director of Fundus Disease Department of Changsha AIER Eye Hospital, Dr.Xiaonin Li, Director of the Department of Optometry, Changsha AIER Eye Hospital, attended the launch meeting.

 


The incidence of high myopia in China has reached 4 percent.

Pathological myopia is the main cause of visual impairment and blindness.

 

image.gif

Prof. ZhiKuan Yang gave a speech.

 


 

The SERI is recognized as a global pioneer in quality eye research, has deeply participated in the development and progress of human ophthalmology. Speaking of AIER, as a global ophthalmic medical group, in terms of abundant clinical resources, AIER has also bridged all three areas of medicine, education, and research, it significantly boosted the industry development and improvement. As early as 2018,, AIER with National Eye Institute of Singapore (referred to as SNEC) & SERI signed a memorandum of strategic cooperation agreement, which outlined the two sides decided to cooperate in academic research, personnel training and technology transformation. For this purpose, to create an "industry-university-research" highland for ophthalmic medical care has been paid close attention.

 


 

As their first collaborative project, the “Adult High Myopia Cohort Study Project “focuses on an emerging public health problem -- pathological myopia.

In recent years, myopia has become a health problem worldwide, especially in Asia. Take China as an example, according to a research report released by the World Health Organization in 2018, there are 600 million myopia patients in China, and the myopia rate among teenagers continues to rank first in the world. What should be more important is that the number of myopias in China is increasing rapidly, with the incidence rate of high myopia reaching 4 percent. As the number of people with high myopia grows, the number of people with pathological myopia causing blindness is also on the rise, posing a serious threat to the nation's vision and visual health. Different with simple myopia, the myopia degree of pathological myopia often does not stabilize with age, this cause myopia to increase later in life. Moreover, pathological myopia which often accompanied with other eye diseases, be like Glaucoma, Cataract, Maculopathy, Retinal Detachment. It's been reported that pathological myopia is one of the leading causes of visual impairment and blindness, both in Asia and globally.

 

 


The project plans to recruit 1,000 patients with high myopia to participate in the research.

 

 

image.gif 


Presentation by Prof. Weizhong Lan

 


 

image.gif 

Project kick-off meeting on-site communication.

 


It is understood that the project will be led by Prof. Zhikuan Yang, Prof. Saw Seangmei, with Prof. Weizhong Lan and Dr. Wong Chee Wai as the project leaders, plans to recruit 1000 high myopia patients over the age of 40 with minimum requirement 500 diopters. Reexaminations will conduct every 12 months during the 5–10-year research period, to evaluate the incidence and risk factors of pathological myopia and the peripheral retinopathy in patients with pathological myopia, as well as explore the impact of daily diet on pathological myopia, and the impact of pathological myopia on the quality of life, with depression and social interaction. At the same time, the research team will use advanced fundus imaging technology to effectively assess and document the complications associated with pathological myopia. To better predict the threatening progress of myopia and explore the pathogenesis of pathological myopia complications, so as to provide solving ideas to the development of high myopia into pathological myopia, team can finally achieve the goal of reducing the blindness rate of high myopia.


 

Prof Aung Tin, Director of the SERI, expressed great pleasure for this project. He said that since the strategic cooperation with AIER has been signed, both sides have been looking for cooperation opportunities. Through this research project, he hopes it will provide the beneficial help on the recognition and treatment of high myopia.

.

 

 

 

Establish a whole chain of myopia research system with a comprehensive life-cycle myopia prevention and control system.

 


 

It is reported that in May 2018, led by AIER School of Ophthalmology CSU, the artificial intelligence product "Cloud Clip" independently developed by AIER as the key experimental equipment, with the world's first myopia big data multi-center research program was officially launched. The project, which based on the research of visual behavior, visual environment and other factors between different regions and races, to ensure the relationship between these factors and individual's myopia development.

 

“Myopia, particularly high myopia does great damage to eye health. We have always exacted but three points in the prevention and control of myopia, First, prevention had to be given more prominence, reduce the overall rate of incidence of myopia; The second, monitor the myopia progress, prevent the occurrence of high myopia; Third, If you have high myopic problem, try to prevent blinding complications.”Prof Zhikuan Yang emphasized “Based on the three points, we have carried out the world's first myopia big data multi-center research program to study the pathogenesis of myopia, as well as the “Adult High Myopia Cohort Project” to study the pathogenesis of pathological myopia. From wide group of myopia research to blind pathological myopia research, we hope work together with scientific research team at home or from overseas in terms of whole chain myopia pathogenesis research systems and solutions, which sets up a comprehensive system for the prevention and control of myopia throughout the human life cycle. Where possible, try to avoid growing blind from myopia at all. A bright future is awaiting China, and the world!